A1 Refereed original research article in a scientific journal
Failure to improve—identifying risk factors for poor functional recovery following chronic subdural hematoma surgery
Authors: Raj, Rahul; Tommiska, Pihla; Luoto, Teemu; Leinonen, Ville; Koivisto, Timo; Tetri, Sami; Posti, Jussi; Lönnrot, Kimmo
Publisher: Oxford University Press (OUP)
Publishing place: OXFORD
Publication year: 2025
Journal: Age and Ageing
Journal name in source: Age and Ageing
Journal acronym: AGE AGEING
Article number: afaf056
Volume: 54
Issue: 3
Number of pages: 10
ISSN: 0002-0729
eISSN: 1468-2834
DOI: https://doi.org/10.1093/ageing/afaf056
Web address : https://doi.org/10.1093/ageing/afaf056
Background: Chronic subdural hematoma (CSDH) is a common condition among older people living with frailty. Outcome after surgery is generally good, but there is a significant proportion of patients who do not benefit from surgery. This study aimed to identify predictors of failure to improve functional outcomes after CSDH surgery.
Methods: This is a post-hoc analysis of the nationwide FINISH trial, which enrolled 589 adult patients undergoing burr-hole drainage for symptomatic CSDH during 2020-22. Functional outcome was assessed using the modified Rankin Scale (mRS). Failure to improve was defined as unchanged or worsened mRS at 6 months compared to preoperative mRS. Multivariable logistic regression was used to identify factors associated with failure to improve.
Results: Of the 568 patients with available mRS data at 6 months, 20% (n = 115) showed no improvement in mRS between the preoperative and 6-month period. Factors associated with failure to improve included pre-existing dementia (OR 2.62, 95% CI 1.21-5.66), use of a walker (OR 3.19, 95% CI 1.64-6.23), smaller hematoma width (OR 0.96, 95% CI 0.93-0.99), and lesser midline shift (OR 0.91, 95% CI 0.86-0.97). Despite this, 88% of patients had stable or improved residence status, and 85% maintained or improved mobility.
Conclusion: A substantial proportion of surgically treated CSDH patients do not improve in functional status. Dementia was a significant predictor of poor outcomes. Future research should focus to better identify patients at risk of poor outcomes in order to avoid overtreatment and explore possible alternative treatment strategies.
Funding information in the publication:
The FINISH trial was supported by a grant from the Finnish State Research Fund for University Level Health Research (Helsinki University Hospital), Finska Lakaresallskapet, Medicinska Understodsforeningen Liv & Halsa and Svenska Kulturfonden. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the article.